Some of you may know that I've been involved in testing of therapeutics with a company called IBEX. Well my results cought the attention of some journalists at the AACR and a PR was issued. Basically I showed that expression of Kallikreins may modify disease progression in an ovarian cancer model in ways that hadn't been anticipated.
Podcast
2 comments:
censoring is fun....
Post a Comment